FDA approves Gleevec, a Targeted Cancer Drug, for children with acute lymphoblastic leukemia

Gleevec, the targeted cancer pill that has saved more than 100,000 lives, now is saving more children with a dire leukemia. The U.S. Food and Drug Administration today approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute lymphoblastic ...



from bankruptcyformssite.com http://ift.tt/1fo8EQ7

via IFTTT